Jiangyue Wu Selected Research

AX 7503

1/2007

Polo-like kinases inhibited by wortmannin. Labeling site and downstream effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiangyue Wu Research Topics

Disease

6	Gestational Diabetes (Gestational Diabetes Mellitus) 06/2021 - 01/2017
3	Neoplasms (Cancer) 01/2016 - 01/2007
1	Body Weight (Weight, Body) 03/2019
1	Congenital Abnormalities (Deformity) 12/2018
1	Weight Gain 12/2018
1	Gestational Weight Gain 12/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 09/2012
1	IronIBA 06/2021
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 12/2018
1	CarbohydratesIBA 11/2018
1	BilirubinIBA 01/2017
1	Estrogen ReceptorsIBA 01/2016
1	Cyclin-Dependent Kinase 4IBA 01/2016
1	Retinoblastoma ProteinIBA 01/2016
1	palbociclibIBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	human ERBB2 proteinIBA 01/2016
1	HydrolasesIBA 09/2012
1	Serine (L-Serine)FDA Link 09/2012
1	Polo-like KinasesIBA 01/2007
1	AX 7503IBA 01/2007

Therapy/Procedure

1	Prenatal Care (Care, Prenatal) 03/2019
1	Therapeutics 09/2012